The efficacy of duloxetine: A comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials

Mallinckrodt, Craig H.; Raskin, Joel; Wohlreich, Madelaine M.; Watkin, John G.; Detke, Michael J.
January 2004
BMC Psychiatry;2004, Vol. 4, p26
Academic Journal
Background: A mixed-effects model repeated measures approach (MMRM) was specified as the primary analysis in the Phase III clinical trials of duloxetine for the treatment of major depressive disorder (MDD). Analysis of covariance using the last observation carried forward approach to impute missing values (LOCF_ANCOVA) was specified as a secondary analysis. Previous research has shown that MMRM and LOCF_ANCOVA yield identical endpoint results when no data are missing, while MMRM is more robust to biases from missing data and thereby provides superior control of Type I and Type II error compared with LOCF_ANCOVA. We compared results from MMRM and LOCF_ANCOVA analyses across eight clinical trials of duloxetine in order to investigate how the choice of primary analysis may influence interpretations of efficacy. Methods: Results were obtained from the eight acute-phase clinical trials that formed the basis of duloxetine's New Drug Application for the treatment of MDD. All 202 mean change analyses from the 20 rating scale total scores and subscales specified a priori in the various protocols were included in the comparisons. Results: In 166/202 comparisons (82.2%), MMRM and LOCF_ANCOVA agreed with regard to the statistical significance of the differences between duloxetine and placebo. In 25/202 cases (12.4%), MMRM yielded a significant difference when LOCF_ANCOVA did not, while in 11/202 cases (5.4%), LOCF_ANCOVA produced a significant difference when MMRM did not. In 110/202 comparisons (54.4%) the p-value from MMRM was lower than that from LOCF_ANCOVA, while in 69/202 comparisons (34.2%), the p-value from LOCF_ANCOVA was lower than that from MMRM. In the remaining 23 comparisons (11.4%), the p-values from LOCF_ANCOVA and MMRM were equal when rounded to the 3rd decimal place (usually as a result of both p-values being < .001). For the HAMD17 total score, the primary outcome in all studies, MMRM yielded 9/12 (75%) significant contrasts, compared with 6/12 (50%) for LOCF_ANCOVA. The expected success rate was 80%. Conclusions: Important differences exist between MMRM and LOCF_ANCOVA. Empirical research has clearly demonstrated the theoretical advantages of MMRM over LOCF_ANCOVA. However, interpretations regarding the efficacy of duloxetine in MDD were unaffected by the choice of analytical technique.


Related Articles

  • Analysis of cross-over studies with missing data. Rosenkranz, Gerd K. // Statistical Methods in Medical Research;Aug2015, Vol. 24 Issue 4, p420 

    This paper addresses some aspects of the analysis of cross-over trials with missing or incomplete data. A literature review on the topic reveals that many proposals provide correct results under the missing completely at random assumption while only some consider the more general missing at...

  • A comparison of power analysis methods for evaluating effects of a predictor on slopes in longitudinal designs with missing data. Wang, Cuiling; Hall, Charles B.; Kim, Mimi // Statistical Methods in Medical Research;Dec2015, Vol. 24 Issue 6, p1009 

    In many longitudinal studies, evaluating the effect of a binary or continuous predictor variable on the rate of change of the outcome, i.e. slope, is often of primary interest. Sample size determination of these studies, however, is complicated by the expectation that missing data will occur due...

  • Introduction to the special issue on joint modelling techniques. Rizopoulos, Dimitris; Lesaffre, Emmanuel // Statistical Methods in Medical Research;Feb2014, Vol. 23 Issue 1, p3 

    Joint modelling techniques have seen great advances in the recent years, with several types of joint models having been developed in literature that can handle a wide range of applications. This special issue of Statistical Methods in Medical Research presents some recent developments from this...

  • Explicating the Conditions Under Which Multilevel Multiple Imputation Mitigates Bias Resulting from Random Coefficient-Dependent Missing Longitudinal Data. Gottfredson, Nisha; Sterba, Sonya; Jackson, Kristina; Gottfredson, Nisha C; Sterba, Sonya K; Jackson, Kristina M // Prevention Science;Jan2017, Vol. 18 Issue 1, p12 

    Random coefficient-dependent (RCD) missingness is a non-ignorable mechanism through which missing data can arise in longitudinal designs. RCD, for which we cannot test, is a problematic form of missingness that occurs if subject-specific random effects correlate with propensity for missingness...

  • Handling Missing Data in a Duloxetine Population Pharmacokinetic/Pharmacodynamic Model - Imputation Methods and Selection Models. Yuen, Eunice; Gueorguieva, Ivelina; Aarons, Leon // Pharmaceutical Research;Oct2014, Vol. 31 Issue 10, p2829 

    Purpose: In pharmacokinetic (PK)/pharmacodynamic (PD) modelling and simulations (M&S), omitting dropouts can cause inaccuracies in parameter estimation and clinical trial simulations (CTS). This study examines the impact of different imputation methods for missing data on the interpretation of...

  • Generalized partially linear mixed-effects models incorporating mismeasured covariates. Hua Liang // Annals of the Institute of Statistical Mathematics;Mar2009, Vol. 61 Issue 1, p27 

    In this article we consider a semiparametric generalized mixed-effects model, and propose combining local linear regression, and penalized quasilikelihood and local quasilikelihood techniques to estimate both population and individual parameters and nonparametric curves. The proposed estimators...

  • Methods for Pooling Results from Multi-center Studies. Worthington, H. // Journal of Dental Research;Jul2004 Supplement 1, pC119 

    A multi-center study is one conducted simultaneously in several participating centers following an agreed protocol, where the randomization has been carried out independently within each center. The main consideration for pooling the data from the individual centers is the choice between a...

  • Quantitative assessment of changes in patients' constructs of quality of life: an application of multilevel models. Lowy, Adam; Bernhard, Jürg; Bernhard, Jürg // Quality of Life Research;Sep2004, Vol. 13 Issue 7, p1177 

    It has often been proposed that quality of life (QL) instruments should account for potentially changing conceptualisations of QL as patients adapt to disease (response-shift). Most instruments do not do this, and some that do are relatively complicated and burdensome for patients. The extent to...

  • Cognitive psychopathology: The role of emotion. Power, Michael J. // Análise Psicológica;Apr-Jun2009, Vol. 27 Issue 2, p127 

    This paper examines the role of emotion in the understanding of psychopathology. The influential Cognitive Therapy model of Beck is briefly reviewed and a number of limitations are considered. Two particular weaknesses are highlighted in the understanding of cognitive psychopathology; namely,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics